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sequences clustered within the Europe/
Turkey clade. The genetic distance be-
tween the 2 strains was 1.15%, but the 
2 sequences were identical at the amino 
acid level. Sequences from the present 
study  showed  96.4%–98.8%  similar-
ity with respective CCHFV sequences 
from  Bulgaria  from  a  former  study 
(BUL10/02  and  BUL1/03)  (3)  but 
differed  from  the  Kosovo  9553/2001 
strain  by  0.8%–2.0%  and  from  the 
Greek 66/08 strain by 1.2%–2.4%.
Two additional suspected CCHF 
cases occurred in the same area, on 
March 30 and April 9 (7). Both per-
sons were negative for CCHFV infec-
tion. All 119 ticks of various species 
(Hyalomma marginatum, Dermacen-
tor marginatus, Rhipicephalus bursa, 
Ixodes  ricinus)  collected  from  the 
area and tested by reverse transcrip-
tion–nested  PCR  were  negative  for 
CCHFV.
This cluster of CCHF cases has 
several important highlights. First, it 
occurred in a region that was consid-
ered to have low CCHF endemicity; 
however, the area is only a few kilo-
meters from Greece, where a human 
fatal case was observed in June 2008 
(8). The index case was observed ear-
lier in the year than in previous years, 
and  clinical  manifestations  of  the 
cases were unusual (absence of cran-
iopharyngeal syndrome and bleeding 
from  gastrointestinal  tract  that  are 
typical for CCHF patients from Bul-
garia); in the fatal case, autopsy of the 
patient showed hemorrhages only in 
the lungs. Two cases were attributable 
to tick exposure, whereas the other 2 
were most likely secondary cases at-
tributable  to  contact  with  the  index 
case-patient  (in  this  regard,  CCHFV 
sequences of the secondary cases were 
almost identical). Finally, the longer 
incubation period of the wife of the 
index case-patient might be associated 
with administration of hyperimmune 
gamma globulin against CCHFV.
In conclusion, CCHF emerged in 
southwestern Bulgaria near the border 
with Greece. Person-to-person trans-
mission emphasizes the need for rapid 
diagnosis of CCHF, especially in cases 
with atypical clinical manifestations.
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Wohlfahrtiimonas 
chitiniclastica  
Bacteremia in 
Homeless Woman
To the Editor: In May 2006, a 
60-year-old homeless woman with a 
history of alcoholism was admitted to 
the emergency department of the Con-
ception  Hospital,  Marseille,  France. 
Firefighters had just found her in an 
abandoned container in the outskirts 
of the city, beside the body of her com-
panion, who had died several days ear-
lier. She described no symptoms other 
than fatigue. On examination, she was 
found  to  be  dirty  and  covered  with 
thousands of body and hair lice; doz-
ens of insect larvae were in her hair. 
She was mildly febrile (38°C) and had 
widespread  excoriations  but  no  sign 
of localized bacterial infection. Head 
shaving  exposed  superficial  ulcers 
on her scalp but no maggots. Blood 
analysis showed marked neutropenia 
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(0.44 ×109/L), thrombocytopenia (28 
× 109/L), a marked but well-tolerated 
iron  deficiency  anemia  (hemoglobin 
6.8g/dL),  and  a  C-reactive  protein 
level of 182 mg/L. Louse infestation 
was treated with a single dose of iver-
mectin (12 mg), and the woman was 
hospitalized. On day 3, she was still 
febrile.  Louse-borne  borreliosis  had 
been  ruled  out  by  a  negative  blood 
smear, and results of serologic testing 
and  molecular  screening  of  lice  for 
the other 2 louse-transmitted bacteria, 
Rickettsia prowazekii and Bartonella 
quintana (1), were negative.
In  contrast,  2  cultures  of  blood 
taken at the time of admission grew 
gram-negative  rods  susceptible  to 
amoxicillin,  ceftriaxone,  imipen-
em,  ciprofloxacin,  amikacin,  and 
trimethoprim/sulfamethoxazole. How-
ever, phenotypic tests failed to identify 
this bacterium with accuracy. Intrave-
nous therapy with ceftriaxone at 2 g/d 
was initiated, and the patient’s fever, 
neutropenia,  and  thrombocytopenia 
improved. Scalp wounds healed with 
local care. Using 16S rRNA gene am-
plification  and  sequencing  as  previ-
ously described (2), we identified the 
bacilli  as  Wohlfahrtiimonas  chitini-
clastica and determined its similarity 
to  be  99.5%  with  strain  E43  (Gen-
Bank  accession  no. AJ517825).  The 
16S  rRNA  sequence  obtained  from 
the  patient’s  strain  was  deposited  in 
GenBank  under  no.  EU484335. The 
strain  was  deposited  in  the  Collec-
tion de Souches de l’Unité des Rick-
ettsies  (CSUR;  World  Data  Center 
for Microorganisms 875, http://ifr48.
timone.univ-mrs.fr/portail2/index.
php?option = com_content&task = vi
ew&id = 96&Itemid = 52) under refer-
ence CSUR P16.
W.  chitiniclastica  is  a  recently 
described  γ-proteobacterium  isolated 
from larvae of the parasitic fly Wohl-
fahrtia  magnifica ( 3).  Although  the 
pathogenicity of this new species for 
humans is as yet undescribed, it is phy-
logenetically close to Ignatzschineria 
larvae,  another  bacterium  associated 
with  W.  magnifica  larvae  (4),  which 
cause severe wound myiasis in cattle 
(5).  Because  of  its  strong  chitinase 
activity, I. larvae may play a role in 
the metamorphosis of its host fly, as 
has been observed for other fly sym-
bionts, and thus may be a symbiont of 
W. magnifica flies (6). The bacterium 
was later discovered in swine waste 
in Quebec (7). In 2007, three publica-
tions renewed researchers’ interest in 
I. larvae. First it was reclassified as 
the only species within the genus Ig-
natzschineria (4). Then 2 case reports 
demonstrated that it plays a role as a 
human pathogen (8,9). Both described 
an I. larvae bacteremia in adults with 
myiasis  in  southeastern  France.  The 
first patient was an elderly farmer with 
diabetes and myiasis of the leg, scro-
tum, and anus (8). The second patient 
was a middle-aged homeless man with 
a history of alcoholism who also had 
foot wound myiasis (9).
We report W. chitiniclastica bac-
teremia  also  in  a  homeless  woman 
from  southeastern  France.  Although 
we did not test body lice for W. chitini-
clastica, we believe that the bactere-
mia originated from the patient’s scalp 
maggots. Unfortunately, as previously 
reported for cases of I. larvae bacte-
remia, the maggots had been rapidly 
discarded, permitting neither bacterial 
analysis  nor  entomologic  identifica-
tion. However, these larvae may have 
been from W. magnifica flies. These 
flies  are  present  in  southern  France, 
and  although  they  are  not  typically 
found at low altitude and in a semiur-
ban environment, their distribution is 
known to be progressively expanding, 
in part because of their broad adapta-
tion  capacities. Animal  hosts  for  W. 
magnifica flies are numerous, but hu-
mans can also be infected; >10 cases 
of this myiasis in humans have been 
reported  in  Europe,  Asia,  Morocco, 
and Egypt. The scalp was affected in 
2 of these patients (10).
Among  homeless  persons,  ec-
toparasitism  is  very  common;  body 
lice  (Pediculus  humanus  humanus) 
are of particular interest because they 
transmit  3  bacterial  bloodstream  in-
fections:  trench  fever  (B.  quintana), 
epidemic typhus (R. prowazekii), and 
louse-borne  relapsing  fever  (Borre-
lia  recurrentis)  (1).  Myiasis  should 
also be considered as a relevant type 
of  ectoparasitism  in  homeless  and 
hygiene-deficient persons. In addition, 
like body lice, ticks, and fleas, fly lar-
vae should also be regarded as another 
potential source of specific arthropod-
borne bacterial systemic infections.
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Serologic  
Screening for  
Neospora caninum, 
France
To the Editor: In the June 2008 
issue of Emerging Infectious Diseas-
es, McCann et al. (1) reported on sero-
logic screening for Neospora caninum 
antibodies and reported a lack of sero-
logic evidence for Neospora infection 
in humans in England, where preva-
lence of infection with the closely re-
lated parasite Toxoplasma gondii also 
is low. Only limited data are available 
on human exposure to Neospora. We 
investigated the seroprevalence of N. 
caninum in humans in France, where 
Toxoplasma  spp.  seroprevalence  is 
high.
Our study comprised 500 serum 
samples  from  healthy  women,  fol-
lowed at the Cochin–Port Royal Uni-
versity  Hospital  in  1997  within  the 
framework of toxoplasmosis surveil-
lance during pregnancy, and 400 serum 
samples  from  HIV-infected  patients. 
All serum samples were submitted to 
anti-Toxoplasma  antibody  testing  by 
using  indirect  immunofluorescence 
(IIF;  Toxo-spot  IFI;  bioMérieux, 
Marcy  l’Etoile,  France)  and  ELISA 
(Platelia Toxo IgG and IgM; BioRad, 
Hercules, CA, USA). An in-house mi-
croplate IIF test previously validated 
in  cattle  was  used  for  simultaneous 
detection of anti-Neospora and anti-
Toxoplasma  immunoglobulin  (Ig)  G 
on the same microplate. All samples 
were screened at dilutions of 1:20 and 
1:80, as is usually done in anti-Toxo-
plasma IIF assays in humans. Corre-
lation  between  the  anti-Toxoplasma 
IIF commercial test and in-house IIF 
was  excellent  (kappa  coefficient  = 
0.98) and allowed us to compare the 
antibody titers against both parasites. 
Forty  (8%)  samples  from  immuno-
competent persons and 21 (4%) from 
immunocompromised persons yielded 
a  weak  fluorescence  when  diluted 
1:20. All but 4 had significant titers of 
anti-Toxoplasma IgG (>200 IU/mL in 
77%  of  cases),  which  suggests  low-
level  cross-reactions.  Whereas  titers 
of >200 and >320 are considered suf-
ficient to diagnose neosporosis in dogs 
and cattle, respectively (2), positivity 
threshold was difficult to resolve in the 
absence of a positive human control. 
We decided on a positivity threshold 
of 1:80, which is similar to the thresh-
old defined by others in further studies 
using  an  indirect  fluorescence  anti-
body test in humans (3,4). None of the 
500 samples from immunocompetent 
persons  were  positive  for  Neospora 
antibodies when assessed at a dilution 
of 1:80. Within the group of immuno-
compromised persons, 3 were positive 
for Neospora antibodies at a titer of 
80, and 1 was positive at a titer of 160. 
Three of these 4 HIV-infected patients 
had high titers of anti-Toxoplasma IgG 
(>2,000 IU/mL), suggesting Toxoplas-
ma  serologic reactivation. We found 
no evidence of Neospora infection or 
exposure  in  immunocompetent  per-
sons  but  could  not  exclude  possible 
Neospora  infection  associated  with 
Toxoplasma  infection  or  reactivation 
in immunocompromised persons.
Taken  together,  our  data  agree 
with data from other studies conduct-
ed in European countries (1,5), which 
suggest  that  neosporosis  in  healthy 
humans  is  unlikely.  However,  the 
Neospora spp. seropositivity of some 
HIV-infected patients, although weak 
compared with the level of seroposi-
tivity in cattle or dogs, could suggest 
circulation of the parasite within im-
munocompromised  hosts,  a  hypoth-
esis  supported  by  Lobato  et  al.  (3). 
However, our observation of a strong 
serologic reactivation against T. gondii 
in 3 of 4 patients with anti-Neospora 
titers  >80  mostly  favors  cross-reac-
tivity involving homologous antigens 
of both parasites and nonspecific an-
tibody binding from polyclonal stimu-
lation of the immune system. Finally, 
one should keep in mind that the posi-
tive predictive value of a serologic test 
used  in  screening  in  low-prevalence 
populations is low. Large-scale stud-
ies are needed to more precisely deter-
mine the potential role of this parasite 
in  immunodeficient  humans  and  to 
isolate the parasite or detect Neospora 
DNA in such patients.
Florence Robert-Gangneux  
and Frédéric Klein
Author  affiliations:  Université  Rennes  1, 
Rennes,  France  (F.  Robert-Gangneux); 
and Laboratoire Départemental de l’Orne, 
Alençon, France (F. Klein)
DOI: 10.3201/eid1506.081414
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 6, June 2009  987 